Aquestive Therapeutics (AQST) FCF Margin (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly FCF Margin of 102.85% for Q1 2026, up 16704.0% year-over-year from N/an in Q1 2025, and down 491.15% quarter-over-quarter from 26.29% in Q4 2025.
Aquestive Therapeutics (AQST) FCF Margin (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' FCF Margin history runs 10 years deep, the most recent figure standing at 102.85% for Q1 2026.
- In Q1 2026, FCF Margin rose 16704.0% year-over-year to 102.85%; the TTM figure through Mar 2026 stood at 657.37% (down 56693.0% YoY), while the FY2025 annual figure was 5595.31%, down 553291.0% from the prior year.
- FCF Margin for Q1 2026 stood at 102.85%, down from 26.29% in the prior quarter.
- The five-year high for FCF Margin was 79.16% in Q1 2023, with the low at 269.9% in Q1 2025.
- The 5-year median for FCF Margin is 65.95% (2023), against an average of 55.06%.
- The sharpest annual moves came in 2023 and 2025: FCF Margin jumped 19804 bps in 2023, then tumbled 18350 bps in 2025.
- Aquestive Therapeutics' FCF Margin stood at 78.54% in 2022, then plunged by 138 bps to 30.01% in 2023, then slumped by 87 bps to 56.02% in 2024, then soared by 147 bps to 26.29% in 2025, then plunged by 491 bps to 102.85% in 2026.
- Business Quant data shows AQST's FCF Margin at 102.85% in Q1 2026, 26.29% in Q4 2025, and 101.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Aquestive Therapeutics | 556.36 Mn | 556.36 Mn | 9.80 Mn | -69.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -69.85% |
| Mar 31, 2026 | -102.85% |
| Dec 31, 2025 | 26.29% |
| Sep 30, 2025 | -101.84% |
| Jun 30, 2025 | -78.60% |
| Mar 31, 2025 | -269.90% |
| Dec 31, 2024 | -56.02% |
| Sep 30, 2024 | -87.73% |
| Jun 30, 2024 | -34.71% |
| Mar 31, 2024 | -86.39% |
| Dec 31, 2023 | -30.01% |
| Sep 30, 2023 | -19.21% |
| Jun 30, 2023 | -65.95% |
| Mar 31, 2023 | 79.16% |
| Dec 31, 2022 | 78.54% |
| Sep 30, 2022 | 22.61% |
| Jun 30, 2022 | -90.49% |
| Mar 31, 2022 | -118.88% |
| Dec 31, 2021 | -77.58% |
| Sep 30, 2021 | -68.85% |